Aimei Health Technology CO., LTD. 8-K Filing
Ticker: AFJKR · Form: 8-K · Filed: Dec 8, 2025 · CIK: 1979005
Sentiment: neutral
Filing Stats: 808 words · 3 min read · ~3 pages · Grade level 13.1 · Accepted 2025-12-08 16:05:37
Key Financial Figures
- $0.0001 — registered Ordinary Shares, par value $0.0001 per share AFJK The Nasdaq Stock Mar
- $34,330.96 — the Termination Date An aggregate of $34,330.96 (the " Extension Payment ") has been de
- $80,000 — holders, representing the lessor of (i) $80,000 for all outstanding public shares and (
- $0.033 — all outstanding public shares and (ii) $0.033 for each outstanding public share for e
- $17,165 — ween the Payees, with each contributing $17,165.48, to fund the Extension Payment. The
- $10.00 — ate units of the Company, at a price of $10.00 per unit, each consisting of one ordina
Filing Documents
- form8-k.htm (8-K) — 48KB
- ex10-1.htm (EX-10.1) — 43KB
- 0001493152-25-026631.txt ( ) — 315KB
- afjk-20251205.xsd (EX-101.SCH) — 4KB
- afjk-20251205_def.xml (EX-101.DEF) — 27KB
- afjk-20251205_lab.xml (EX-101.LAB) — 37KB
- afjk-20251205_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 7KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 8, 2025 Aimei Health Technology Co., Ltd By: /s/ Junheng Xie Name: Junheng Xie Title: Chief Executive Officer and Director (Principal Executive Officer)